, India
Photo from Envato

India’s pharmaceutical sector faces challenges amidst weak IP regime

Applicants seeking market approval encounter uncoordinated processes amongst federal and state agencies.

India’s pharmaceutical industry is projected to hit $42.9b by 2028 with a compound annual growth rate of 6.3% in local currency terms. However, a weak IP regime poses a challenge to the sector's potential expansion.

A BMI report said that Section 3(d) of the Patent Act undermines incentives for biopharmaceutical innovation, as it restricts patentability for improvements unrelated to efficacy.

Another major challenge for biopharmaceutical applicants seeking market approval is the opaque and uncoordinated process among federal and state agencies.

“Four years after a medicine's initial approval in India, simply obtaining a license from any state drug regulator is sufficient to manufacture and market the product, causing harm to innovators, and subsequent producers,” the report said.

Moreover, The 2024 Special 301 Report issued by the U.S. Trade Representative highlighted the country’s burdensome formalities for IP filing and significant delays in processing.

“An unpredictable IP regime may deter innovators from entering the market at the pace required by the National Biotech Strategy,” BMI added.

 

Follow the links for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.